← FDA Drug Approvals (Drugs@FDA)

LUMISIGHT

NDA · New Drug Application · Sponsor: LUMICELL · Approved 2024-04-17

Drug application

FDA Application #

NDA214511

Application type

New Drug Application

Brand name

LUMISIGHT

Generic name

PEGULICIANINE

Active ingredients

PEGULICIANINE ACETATE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

LUMICELL

Manufacturer

Lumicell, Inc.

First approval

2024-04-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown